Your Benefits

EXTENSIVE SCHEME OFFERING

Boasting the largest selection of molecular EQA schemes for infectious disease
testing, you are sure to find what you’re looking for.

FREQUENCY

Choose between one, two and four challenges* per year to suit your laboratory
requirements. Reports are available within 2 weeks of the submission deadline
(up to 4 weeks for the drug resistance / sequence based schemes), ensuring any
corrective actions can be taken quickly.

HIGH QUALITY MATERIAL

The availability of whole pathogen samples in clinically relevant matrices mimics the
performance of patient samples and ensures samples can be used to effectively
monitor the performance of the entire testing process.

INTERNATIONAL ACCREDITATION

Where appropriate the EQA schemes are accredited to ISO 17043 highlighting
the superior quality and organisation of the QCMD scheme.

ONLINE EQA MANAGEMENT SYSTEM

QCMD’s IT EQA Management System (ITEMS) provides an online tool to easily
manage all EQA activities from registration to submission of results and provision
of EQA reports.

HIGH LEVEL OF PARTICIPATION

With over 15000 participant registrations in more than 120 countries, peer groups
are maximised, increasing statistical validity.

COMPREHENSIVE REPORTS

Individual reports are provided with each EQA challenge. In line with the
requirements of ISO 17043, they provide the laboratories with their results and
performance assessment in relation to their EQA assessment group (peer review group).

Supplementary reports which include scientific expert commentary may be
provided at the end of the EQA cycle if appropriate.

*scheme dependent